We are live on ! Find out more
BP

BBR Partners Portfolio holdings

AUM $1.79B
1-Year Est. Return 16.83%
This Fund
S&P 500
This Quarter Est. Return
-4.73%
1 Year Est. Return
+16.83%
3 Year Est. Return
+51.59%
5 Year Est. Return
+58.21%
10 Year Est. Return
+227.69%
AUM
$1.42B
AUM Growth
-$17M
Cap. Flow
+$66.7M
Cap. Flow %
4.71%
Top 10 Hldgs %
72.42%
Holding
262
New
12
Increased
41
Reduced
74
Closed
17

Top Buys

Rank Stock Value
1
KKR icon
KKR & Co
KKR
+$61.1M
2
DMRC icon
Digimarc Corp
DMRC
+$15.9M
3
MLAB icon
Mesa Laboratories
MLAB
+$3.76M
4
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$2.13M
5
PSX icon
Phillips 66
PSX
+$1.33M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$5.17M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$3.5M
3
ACI icon
Albertsons Companies
ACI
+$1.96M
4
AAPL icon
Apple
AAPL
+$969K
5
WDC icon
Western Digital
WDC
+$894K

Sector Composition

Rank Sector Weight
1 Industrials 10.57%
2 Financials 9.61%
3 Technology 7.22%
4 Consumer Staples 3.64%
5 Healthcare 2.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRML
226
DELISTED
Tourmaline Bio
TRML
$152K 0.01%
+10,000
New +$160K
VMD icon
227
Viemed Healthcare
VMD
$451M
$109K 0.01%
15,000
– –
MRT icon
228
Marti Technologies
MRT
$176M
$109K 0.01%
35,000
– –
THRD
229
DELISTED
Third Harmonic Bio
THRD
$104K 0.01%
+30,000
New +$145K
SOND
230
DELISTED
Sonder
SOND
$100K 0.01%
50,000
– –
HTZWW
231
Hertz Global Holdings Warrants
HTZWW
$74.7M
$91.9K 0.01%
40,649
– –
IMA
232
ImageneBio Inc
IMA
$63.1M
$89.6K 0.01%
5,833
– –
LYEL icon
233
Lyell Immunopharma
LYEL
$309M
$88.3K 0.01%
8,202
– –
LFST icon
234
Lifestance Health
LFST
$4.16B
$85.7K 0.01%
12,873
– –
CNDT icon
235
Conduent
CNDT
$230M
$81K 0.01%
30,000
– –
MGX icon
236
Metagenomi Therapeutics
MGX
$45.4M
$72.6K 0.01%
53,403
– –
LOCL icon
237
Local Bounti
LOCL
$24.2M
$60.3K ﹤0.01%
29,293
– –
BLND icon
238
Blend Labs
BLND
$409M
$48.1K ﹤0.01%
14,357
– –
OABI icon
239
OmniAb
OABI
$294M
$48K ﹤0.01%
20,000
– –
ALLO icon
240
Allogene Therapeutics
ALLO
$601M
$42.3K ﹤0.01%
28,952
– –
ENZ
241
DELISTED
Enzo Biochem, Inc.
ENZ
$37K ﹤0.01%
100,000
– –
SMRT icon
242
SmartRent
SMRT
$183M
$26.1K ﹤0.01%
+21,551
New +$30.2K
PRPL icon
243
Purple Innovation
PRPL
$33.2M
$18.2K ﹤0.01%
960
– –
KYNB
244
Kyntra Bio
KYNB
$28.5M
$5.1K ﹤0.01%
658
– –
TPHS
245
DELISTED
Trinity Place Holdings Inc.com
TPHS
$2.89K ﹤0.01%
60,000
– –
ACI icon
246
Albertsons Companies
ACI
$5.4B
– –
-100,000
Closed -$1.96M
AEON icon
247
AEON Biopharma
AEON
$11.1M
– –
-161
Closed -$6.26K
FDX icon
248
FedEx
FDX
$74.5B
– –
-822
Closed -$231K
GBDC icon
249
Golub Capital BDC
GBDC
$3.33B
– –
-43,331
Closed -$657K
HON icon
250
Honeywell
HON
$77.1B
– –
-1,232
Closed -$262K
7 8 9
10
11

Similar funds

CIM
Cambria Investment Management Manhattan Beach, California $1.79B AUM 28.1% 1-Year Est. Return
JCM
Jacobi Capital Management Pittston, Pennsylvania $1.79B AUM 17.94% 1-Year Est. Return
WIM
WealthPlan Investment Management Omaha, Nebraska $1.79B AUM 17.59% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
KPM
Kinetic Partners Management Miami, Florida $1.79B AUM 57.3% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return
GC
Gobi Capital San Francisco, California $1.8B AUM 7.28% 1-Year Est. Return
EFS
Essex Financial Services Essex, Connecticut $1.78B AUM 23.37% 1-Year Est. Return

BBR Partners's Q1 2025 Portfolio in Review

As of Q1 2025, BBR Partners held 262 positions worth $1.42B, down 1.2% from $1.43B the previous quarter. Its ten largest holdings account for 72% of the portfolio.

BBR Partners deployed $66.7M of net new capital in Q1 2025, opening 12 new positions and adding to 41 existing holdings. Its largest new stake was Digimarc Corp: 556,095 shares worth $7.13M.

By sector, the portfolio is most concentrated in Industrials at 11% of assets, down from 12% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Humana, an estimated $5.17M trimmed.

  • BBR Partners's largest Q1 2025 buy was Digimarc Corp: 556,095 shares worth $7.13M.
  • BBR Partners added most to KKR & Co in Q1 2025, an estimated $61.1M increase.
  • BBR Partners's biggest Q1 2025 reduction was Humana, cutting an estimated $5.17M.
  • BBR Partners fully exited Albertsons Companies in Q1 2025, selling an estimated $1.96M.
  • BBR Partners's ten largest holdings make up 72% of its $1.42B portfolio in Q1 2025.
  • BBR Partners opened 12 new positions and closed 17 in Q1 2025.
  • BBR Partners's portfolio value fell 1.2% quarter-over-quarter to $1.42B.

Based on BBR Partners's 13F filing for Q1 2025, filed 14 May 2025.